Selective Androgen Receptor Modulators (SARMs) Negatively Regulate Triple-Negative Breast Cancer Growth and Epithelial:Mesenchymal Stem Cell Signaling

INTRODUCTION: The androgen receptor (AR) is the most highly expressed steroid receptor in breast cancer with 75–95% of estrogen receptor (ER)-positive and 40–70% of ER-negative breast cancers expressing AR. Though historically breast cancers were treated with steroidal androgens, their use fell from...

Descripción completa

Detalles Bibliográficos
Autores principales: Narayanan, Ramesh, Ahn, Sunjoo, Cheney, Misty D., Yepuru, Muralimohan, Miller, Duane D., Steiner, Mitchell S., Dalton, James T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114483/
https://www.ncbi.nlm.nih.gov/pubmed/25072326
http://dx.doi.org/10.1371/journal.pone.0103202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114483/
https://www.ncbi.nlm.nih.gov/pubmed/25072326
http://dx.doi.org/10.1371/journal.pone.0103202

Ejemplares similares